Cabaletta Bio Inc reports results for the quarter ended in March - Earnings Summary

Cabaletta Bio

15/05/2024 13:45

* Cabaletta Bio Inc  CABA.OQ  reported a quarterly adjusted
loss
of 51 cents​​ per share for the quarter ended in March, lower
than the same quarter last year, when the company reported EPS
of -45 cents.  The mean expectation of ten analysts for the
quarter was for a loss of 48 cents per share. Wall Street
expected results to range from -66 cents to -31 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Cabaletta Bio Inc's reported EPS for the quarter was a
loss
of 51 cents​.
    * The company reported a quarterly loss of $25.05 million.
    * Cabaletta Bio Inc shares had fallen by 34.2% this
quarter and
lost 50.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 8.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Cabaletta Bio Inc
is $33.00 
This summary was machine generated from LSEG data May 15 at
12:44 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.48          -0.51          Missed
 Dec. 31 2023      -0.39          -0.46          Missed
 Sep. 30 2023      -0.40          -0.37          Beat
 Jun. 30 2023      -0.44          -0.37          Beat